Stock Valuation / CVS
Is CVS Health Corporation (CVS) Overvalued? Fair Value & 5-Year Target
CVS Health Corporation trades at $87.55 (P/E 23.10). Our reference model estimates a fair value of $67.60 at its recent average P/E of 17.84.
| Current price | $87.55 |
|---|---|
| Current EPS | $3.79 |
| Current P/E | 23.10 |
| Average P/E | 17.84 |
| Fair value (at avg P/E) | $67.60 |
| Upside to fair value | -22.8% |
| Illustrative 5-yr target (25× P/E, 15% growth) | $190.58 |
What drives CVS's valuation
Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management s
Frequently asked questions
What is CVS's fair value?
At its recent average P/E of 17.84, CVS Health Corporation (CVS) has a reference fair value of about $67.60, which is -22.8% versus the current price of $87.55.
Is CVS Health Corporation (CVS) overvalued or undervalued?
Based on the average-P/E reference model, CVS Health Corporation looks overvalued relative to fair value by roughly +22.8%. This is a model output, not investment advice — change the P/E and growth assumptions in the dashboard for your own view.
What is a 5-year price target for CVS?
Under an illustrative model of 25× P/E and 15% annual EPS growth, the implied 5-year target is $190.58. Adjust both inputs on the interactive page to match your assumptions.
Open the interactive CVS valuation dashboard →
Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.